Ares Capital Corp (ARCC) · Nov 20, 2026 · Material agreement
10bp spread cut — 1.80% / 2.30% pricing versus 1.90% / 2.40% previously
Ares Capital’s latest funding amendment cuts BNP facility spreads, but tighter collateral eligibility limits how aggressively new loans can be financed.
Ares Capital is a large middle-market direct lender using several secured facilities to fund loan growth; as of September 30, 2026, its BNP Funding Facility had $1.465 billion of commitments and $733 million outstanding, while its investment backlog was approximately $2.5 billion.
The headline change is a modest funding-cost improvement. The eleventh amendment reduces the BNP facility’s spread by 10 basis points during the reinvestment period and by another 10 basis points afterward. That is economically helpful, but small relative to ARCC’s overall debt base and does not add borrowing capacity. Unlike the June 2026 tenth amendment, which increased this facility by $200 million, this filing is primarily a repricing and rule change.
The trade-off is tighter borrowing-base discipline. Newly acquired collateral loans receive a 0% advance rate until they are elevated to assignments, meaning ARCC cannot immediately finance those assets through this facility. 〔0〕 The amendment also adds or tightens eligibility screens, including a minimum $10 million EBITDA threshold for most non-recurring-revenue borrowers. 〔1〕
Overall, this improves economics without changing the business story. ARCC gets slightly cheaper financing on an existing warehouse facility, but the new collateral rules limit flexibility in funding fresh loans and favor more seasoned or higher-quality assets. The net effect is modestly positive, not a meaningful expansion of lending capacity.
Bottom line: This is a small financing win paired with tighter collateral controls. It supports ARCC’s lending engine but does not materially change its growth or risk profile.
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!